Mereo BioPharma (MREO) Operating Income (2023 - 2026)
Mereo BioPharma (MREO) reported Operating Income of -$8.8 million for Q1 2026, up 21.75% year-over-year from -$7.2 million in Q1 2025, and down 4.48% quarter-over-quarter from -$8.4 million in Q4 2025.
Mereo BioPharma (MREO) Operating Income (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Operating Income data on file, last reported at -$8.8 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$8.8 million, up 21.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$37.7 million (down 493.91% YoY), and the FY2025 annual result was -$40.1 million, down 469.21% from the prior year.
- Operating Income slipped to -$8.8 million in Q1 2026 per MREO's latest filing, from -$8.4 million in the prior quarter.
- Over five years, Operating Income peaked at $43.0 million in Q4 2024 and troughed at -$12.8 million in Q2 2024.
- A 4-year average of -$5.1 million and a median of -$9.4 million in 2024 frame the typical range for Operating Income.
- On a YoY basis, Operating Income climbed as much as 702.58% in 2024 and fell as far as 1480.02% in 2024.
- A 4-year view of Operating Income shows it stood at -$7.1 million in 2023, then jumped by 702.58% to $43.0 million in 2024, then slumped by 119.53% to -$8.4 million in 2025, then fell by 4.48% to -$8.8 million in 2026.
- Business Quant data shows MREO's Operating Income at -$8.8 million in Q1 2026, -$8.4 million in Q4 2025, and -$10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | -8.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.77 Mn |
| Dec 31, 2025 | -8.39 Mn |
| Sep 30, 2025 | -10.02 Mn |
| Jun 30, 2025 | -10.50 Mn |
| Mar 31, 2025 | -11.20 Mn |
| Dec 31, 2024 | 42.95 Mn |
| Sep 30, 2024 | -9.37 Mn |
| Jun 30, 2024 | -12.81 Mn |
| Mar 31, 2024 | -9.90 Mn |
| Dec 31, 2023 | -7.13 Mn |
| Sep 30, 2023 | -9.07 Mn |
| Jun 30, 2023 | -811,000.00 |
| Mar 31, 2023 | -11.41 Mn |